Venanzi V, Ciofini S, Antonioli E, Buda G, Bestoso E, Raspadori D, Candi V, Pengue L, Del Giudice M, Caremani A, Moretti S, Fontanelli G, Attucci I, Pirrotta MT, Biagiotti C, Birtolo S, Grammatico S, Pilerci S, Notarfranchi L, Tancredi G, Galimberti S, Bocchia M, Gozzetti A. P23 | DARA-VTD AND ASCT+ LENALIDOMIDE LED TO HIGH COMPLETE REIMISSION AND MINIMAL RESIDUAL DISEASE NEGATIVITY RATES BY NGF: A REAL-WORLD STUDY OF THE TUSCAN MYELOMA NETWORK IN 228 PATIENTS. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14065.